Skip to main content

Market Overview

Why Axcella Health's Stock Is Trading Higher


Axcella Health (NASDAQ: AXLA) shares are trading higher on Thursday, after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $28 per share.

Axcella Health a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. The company's pipeline comprises five programs focused on the metabolic functions of the liver, muscle, and blood.

Axcella Health shares were trading up 10.25% at $5.70 at time of publication on Thursday. The stock has a 52-week high of $15.25 and a 52-week low of $2.25.

Related Links:

UK Clears Gilead's Remdesivir For Some Coronavirus Patients

10 Biopharmaceutical Companies Trying To Cure Cancer

Latest Ratings for AXLA

Jun 2021Chardan CapitalMaintainsBuy
Oct 2020Chardan CapitalInitiates Coverage OnBuy
Oct 2020SVB LeerinkAssumesOutperform

View More Analyst Ratings for AXLA
View the Latest Analyst Ratings


Related Articles (AXLA)

View Comments and Join the Discussion!

Posted-In: why it's movingPrice Target Initiation Analyst Ratings

Latest Ratings

FIGSGoldman SachsInitiates Coverage On28.0
LBRTB of A SecuritiesUpgrades15.8
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at